co.don Future Growth
Future criteria checks 0/6
Wir verfügen derzeit nicht über ausreichende Analystenabdeckung, um Wachstum und Umsatz für co.don zu prognostizieren.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Biotechs earnings growth | 33.4% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
Recent updates
Here's Why co.don (ETR:CNW) Can Afford Some Debt
Oct 06Health Check: How Prudently Does co.don (ETR:CNWK) Use Debt?
May 06Will co.don (ETR:CNWK) Spend Its Cash Wisely?
Mar 15Analysts Expect Breakeven For co.don AG (ETR:CNWK) Before Long
Feb 08co.don's(ETR:CNWK) Share Price Is Down 85% Over The Past Three Years.
Jan 04In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as co.don has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2022 | 10 | -14 | -8 | -8 | N/A |
3/31/2022 | 10 | -12 | -8 | -8 | N/A |
12/31/2021 | 10 | -9 | -8 | -8 | N/A |
9/30/2021 | 8 | -10 | -9 | -9 | N/A |
6/30/2021 | 7 | -11 | -10 | -10 | N/A |
3/31/2021 | 6 | -13 | -10 | -10 | N/A |
12/31/2020 | 6 | -14 | -10 | -9 | N/A |
9/30/2020 | 6 | -15 | -11 | -10 | N/A |
6/30/2020 | 7 | -16 | -13 | -10 | N/A |
3/31/2020 | 7 | -14 | -13 | -10 | N/A |
12/31/2019 | 7 | -13 | -14 | -10 | N/A |
9/30/2019 | 6 | -11 | -15 | -9 | N/A |
6/30/2019 | 6 | -9 | -16 | -8 | N/A |
3/31/2019 | 6 | -7 | -16 | -8 | N/A |
12/31/2018 | 6 | -6 | -16 | -8 | N/A |
9/30/2018 | 6 | -7 | N/A | N/A | N/A |
6/30/2018 | 6 | -8 | N/A | N/A | N/A |
3/31/2018 | 6 | -8 | N/A | N/A | N/A |
12/31/2017 | 6 | -7 | -10 | -6 | N/A |
9/30/2017 | 6 | -6 | N/A | N/A | N/A |
6/30/2017 | 6 | -5 | N/A | N/A | N/A |
3/31/2017 | 6 | -4 | N/A | N/A | N/A |
12/31/2016 | 6 | -4 | -4 | -4 | N/A |
9/30/2016 | 6 | -3 | N/A | N/A | N/A |
6/30/2016 | 6 | -3 | N/A | N/A | N/A |
3/31/2016 | 5 | -3 | N/A | N/A | N/A |
12/31/2015 | 5 | -3 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von CNW über der Sparquote liegt (0.03%).
Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von CNW schneller wachsen werden als der Markt German
Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von CNW in den nächsten 3 Jahren signifikant steigen werden.
Einnahmen vs. Markt: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von CNW schneller wachsen werden als der Markt von German.
Hohe Wachstumseinnahmen: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Einnahmen von CNW schneller wachsen werden als 20% pro Jahr.
Earnings per Share Growth Forecasts
Future Return on Equity
Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von CNW in 3 Jahren voraussichtlich hoch sein wird